Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Sitemap |
  5. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Our Company

Contact

Sanofi

Sanofi House
44 on Grand Central Office Park
2 Bond Street
Grand Central Extension 1
Midrand 16

Tel: +27 (0)11 256 3700
Fax: +27 (0)11 847 5099

If your question is related to an emergency, please consult your doctor or emergency unit.

Medical Information and Pharmacovigilance


Content :

Manufacturing Facility

Committed to local manufacturing, the organisation has a production site in Waltloo, Pretoria, which manufactures and packages a wide range of pharmaceutical products. The manufacturing facility is a key pillar for Sanofi’s development. It supports the company’s global growth strategy and its choices are aligned with the Group's mission of “focusing on patients’ needs”. Control of the production and distribution chain ensures the safety and quality of medicines for patients.

Waltloo Production Facility

One of the best pharmaceutical plants in South Africa

  • Established by Noristan in 1972.
  • Fully upgraded by Hoechst to comply with latest international quality and health and safety standards in 1999, producing and analysing tablets, capsules, liquids, creams and ointments.
  • MCC approved and used as a training site.
  • PICS accredited (2009) and AIFA accredited (2011)
  • In order to increase production activity, negotiated toll manufacture of ARVs in 2007. Pharmachoice vitamins workshop established in 2008 and TB (Botsogo) facility established to supply all markets with TB products in 2010.

Our commitment to local manufacturing

Support for government’s National Industry Policy Framework (NIPF)

  • Invested R7mio in a solid dosage facility and warehouse extension in 2011.
  • Health, Safety & Environment: ISO 14001 approved 2012
  • EU approved accredited manufacturing plant
  • Global center of excellence, research and production of TB products for the SA and Global markets
  • R10mil investment for 2013 ARV manufacturing
  • Annually R10mil investment for continuous upgrades & capacity building
  • Train MCC Inspectors and their African Counterparts

Updated June 20, 2013

Module :

Corporate Information

Corporate Information